Publisher
Springer Science and Business Media LLC
Reference78 articles.
1. Peck CC. Rationale for the effective use of pharmacokinetics and pharmacodynamics in early drug development. In: Yacobi A, Skelly JP, Shah VP, et al. eds. Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development. New York, NY: Plenum Press; 1993. 1–5.
2. Reigner BG, Williams PE, Patel IH, et al. An evaluation of the integration of pharmacokinetic and pharmacodynamic principles in clinical drug development: experience within Hoffmann La Roche. Clin Pharmacokinet. 1997; 33(2): 142–152.
3. Peck CC, Barr WH, Benet LZ, et al. Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development. Int J Pharm. 1992; 82: 9–19.
4. Derendorf H, Lesko LJ, Chaikin P, et al. Pharmacokinetic/pharmacodynamic modeling in drug research and development. J Clin Pharmacol. 2000; 40(12 pt 2): 1399–1418.
5. Holford NH, Sheiner LB. Pharmacokinetic and pharmacodynamic modeling in vivo. CRC Crit Rev Bioeng. 1981; 5(4): 273–322.
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献